Envoy Medical Reports Second Quarter 2024 Results, Provides Business Update

The company continues to make significant progress in disrupting the existing cochlear implant industry with its research-led, groundbreaking, fully implanted Acclaim cochlear implant; Maintains goal to initiate Pivotal Clinical Trial by end of year

WHITE BEAR LAKE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) — Envoy Medical, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing aids, today announced business and financial results for the second quarter ended June 30, 2024.